These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12498653)

  • 21. A live attenuated West Nile virus strain as a potential veterinary vaccine.
    Lustig S; Olshevsky U; Ben-Nathan D; Lachmi BE; Malkinson M; Kobiler D; Halevy M
    Viral Immunol; 2000; 13(4):401-10. PubMed ID: 11192286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design.
    Yamshchikov V; Manuvakhova M; Rodriguez E
    Virology; 2016 Jan; 487():198-206. PubMed ID: 26545140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain.
    Kumar M; O'Connell M; Namekar M; Nerurkar VR
    Viruses; 2014 Jun; 6(6):2328-39. PubMed ID: 24915459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
    Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
    J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.
    Xia J; Winkelmann ER; Gorder SR; Mason PW; Milligan GN
    J Virol; 2013 Nov; 87(22):12090-101. PubMed ID: 23986602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations.
    Schlick P; Kofler RM; Schittl B; Taucher C; Nagy E; Meinke A; Mandl CW
    Vaccine; 2010 Aug; 28(36):5903-9. PubMed ID: 20600500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus).
    Turell MJ; Bunning M; Ludwig GV; Ortman B; Chang J; Speaker T; Spielman A; McLean R; Komar N; Gates R; McNamara T; Creekmore T; Farley L; Mitchell CJ
    Emerg Infect Dis; 2003 Sep; 9(9):1077-81. PubMed ID: 14519243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
    PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
    Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
    Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.
    Yamshchikov G; Borisevich V; Seregin A; Chaporgina E; Mishina M; Mishin V; Kwok CW; Yamshchikov V
    Virology; 2004 Dec; 330(1):304-12. PubMed ID: 15527855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of neutralizing antibodies in reindeer (Rangifer tarandus) after administration of a killed West Nile virus vaccine.
    Palmer MV; Waters WR; Pedersen DD; Stoffregen WC
    J Wildl Dis; 2004 Oct; 40(4):759-62. PubMed ID: 15650096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.